HST Global Inc. logo

HST Global Inc. (HSTC)

Market Closed
18 Jun, 20:00
OTC PINK OTC PINK
$
0. 70
0
0%
$
29.94M Market Cap
- P/E Ratio
- Div Yield
300 Volume
0 Eps
$ 0.7
Previous Close
Add Transaction
Day Range
0.7 0.7
Year Range
0 1.05
Want to track HSTC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

HSTC closed yesterday higher at $0.7, an increase of 0% from Wednesday's close, completing a monthly decrease of -29.2929% or -$0.29. Over the past 12 months, HSTC stock lost -30%.
HSTC is not paying dividends to its shareholders.
The last earnings report, released on Dec 31, 2016, missed the consensus estimates by -0.0178%. On average, the company has fell short of earnings expectations by -0.0178%, based on the last three reports.
HST Global Inc. has completed 3 stock splits, with the recent split occurring on Nov 26, 2019.
The company's stock is traded on one exchange.

HSTC Chart

People also search for

VicapSys Life Sciences Inc.
$ 1.46
0%
Quantumzyme Corp.
$ 0.8
+33.3333%
Positive Physicians Holdings, Inc.
$ 8.5
0%
Healixa Inc.
$ 0.04
0%
Provectus Biopharmaceuticals, Inc.
$ 0.06
0%

HST Global Inc. (HSTC) FAQ

What is the stock price today?

The current price is $0.70.

On which exchange is it traded?

HST Global Inc. is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is HSTC.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 29.94M.

Has HST Global Inc. ever had a stock split?

HST Global Inc. had 3 splits and the recent split was on Nov 26, 2019.

HST Global Inc. Profile

Biotechnology Industry
Healthcare Sector
Michael Fortkort CEO
OTC PINK Exchange
40432E202 CUSIP
US Country
1 Employees
- Last Dividend
7 Jul 2008 Last Split
- IPO Date

Overview

HST Global, Inc. is a dynamically positioned health and wellness biotechnology company that has set its sights on the development and acquisition of wellness centers both within the United States and internationally. Specializing in the homeopathic and alternative treatment methodologies for patients suffering from late-stage cancer, the company stands at the forefront of offering nuanced health solutions. Moreover, HST Global, Inc. leverages its expertise in the field to focus on the research and development of homeopathic and alternative product candidates. These products are primarily aimed at treating late-stage cancers and other life-threatening conditions, and they either are undergoing clinical trials or have already completed them, showcasing the company’s commitment to innovating within the health sector. Based in Hampton, Virginia, HST Global, Inc. is strategically positioned to make significant contributions to the health and wellness industry on a global scale.

Products and Services

  • Wellness Centers

HST Global, Inc. develops and acquires a network of wellness centers that focus on offering homeopathic and alternative treatments for patients with late-stage cancer. These centers are designed to provide holistic and personalized care, emphasizing treatments that go beyond conventional medicine. They are accessible both in the United States and internationally, making advanced cancer care more widely available.

  • Homeopathic and Alternative Product Candidates

The company is actively involved in the development and advancement of homeopathic and alternative product candidates. These products are aimed at not only treating late-stage cancers but also addressing other life-threatening diseases. With some products already having completed clinical trials, and others currently in the testing phase, HST Global, Inc. is at the cutting edge of offering innovative and alternative therapeutic options to patients in need.

Contact Information

Address: 150 Research Drive
Phone: 757 766 6100